@article{f17155a451b849449e52f0988b460298,
title = "Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era",
keywords = "Angiographic classification and patterns, Bifurcation lesions, Everolimus eluting stent, In-stent-restenosis",
author = "Meelu, {Omar A.} and Mennuni, {Marco G.} and Kleanthis Theodoropoulos and Samantha Sartori and Usman Baber and Roxana Mehran and Sharma, {Samin K.} and Kini, {Annapoorna S.} and Dangas, {George D.}",
note = "Funding Information: RM and GDD have institutional research grant support from The Medicines Co. , Bristol-Myers Squibb/Sanofi-Aventis , Lilly/Daiichi Sankyo , Regado Biosciences and STENTYS ; and consulting fees/honoraria from Abbott Vascular , Astra Zeneca , Bayer , Boston Scientific , Covidien , CSL Behring , GE Healthcare , Janssen (JNJ) , Maya Medical , Merk Co. , and Osprey Medical . SKS is on the speaker{\textquoteright}s bureau of BSC, Abbott, Medicine Co., and Lilly/Daiichi-Sankyo. ASK serves on the speakers{\textquoteright} bureau of the ACC and has received consulting fees from WebMD.",
year = "2017",
month = mar,
doi = "10.1016/j.hjc.2016.08.003",
language = "English",
volume = "58",
pages = "167--168",
journal = "Hellenic Journal of Cardiology",
issn = "1109-9666",
publisher = "Hellenic Cardiological Society",
number = "2",
}